CANAAN X L.P.'s Net Worth
$175 Million
Who is CANAAN X L.P.?
CANAAN X L.P. has an estimated net worth of $175 Million. This is based on reported shares across multiple companies, which include Protagonist Therapeutics, Inc, Astra Space, Inc., IDEAYA Biosciences, Inc., Iterum Therapeutics plc, and NextCure, Inc..
SEC CIK
CANAAN X L.P.'s CIK is 0001619859
Past Insider Trading and Trends
2019 was CANAAN X L.P.'s most active year for acquiring shares with 8 total transactions. CANAAN X L.P.'s most active month to acquire stocks was the month of April. 2018 was CANAAN X L.P.'s most active year for disposing of shares, totalling 16 transactions. CANAAN X L.P.'s most active month to dispose stocks was the month of April. 2016 saw CANAAN X L.P. paying a total of $6,999,996.00 for 2,453,255 shares, this is the most they've acquired in one year. In 2018 CANAAN X L.P. cashed out on 1,563,217 shares for a total of $4,041,732.02, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Protagonist Therapeutics, Inc (PTGX) Snapshot price: $41.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.81% | -38.97K |
$6.09 | -$237,357.98 | 2.12M |
May 17
| |||
Form 4
| -7.10% | -164.75K |
$6.42 | -$1,058,374.50 | 2.16M |
May 14 - May 16
| |||
Form 4
| -2.52% | -59.95K |
$20.71 | -$1,241,324.70 | 2.32M |
Mar 23
| |||
Form 4
| -1.63% | -39.52K |
$20.61 | -$814,398.15 | 2.38M |
Mar 20 - Mar 22
| |||
Form 4
| -0.83% | -20.36K |
$20.55 | -$418,508.25 | 2.42M |
Mar 16 - Mar 19
| |||
Form 4
| -0.54% | -13.15K |
$20.66 | -$271,768.43 | 2.44M |
Mar 13 - Mar 15
| |||
Form 4
|
∞
| 2.45M |
$12.00 |
—
| 2.45M |
Aug 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Astra Space, Inc. (ASTR) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -20.30% | -4.20M |
—
|
—
| 16.49M |
Dec 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IDEAYA Biosciences, Inc. (IDYA) Snapshot price: $36.21
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.66M |
$10.00 |
—
| 2.66M |
May 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Iterum Therapeutics plc (ITRM) Snapshot price: $1.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
|
∞
| 1.73M |
$13.00 |
—
| 1.73M |
May 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NextCure, Inc. (NXTC) Snapshot price: $1.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.25M |
$15.00 |
—
| 2.25M |
May 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||